The company
As a specialist in-vitro diagnostic company, BÜHLMANN Laboratories focuses on the development and production of tests for gastrointestinal inflammation and allergies. Leveraging a scalable, open-systems business model, the company has established long-term partnerships with global instrument manufacturers. This ensures that patients worldwide can benefit from cost-effective, accurate, and reliable tests for diagnosis and disease management. BÜHLMANN Laboratories was acquired from Dr Bühlmann who founded the company in Basel in 1976.
The market
In-vitro diagnostic (IVD) tests play an integral part in modern healthcare and a vital role in the detection and monitoring of chronic conditions. They are widely used by clinical laboratories, gastroenterologists, researchers, and patients in the shape of home-testing products. By measuring key biomarkers, these diagnostic tools allow non-invasive assessment of gastrointestinal inflammation. This facilitates more accurate diagnoses and improved disease management, as well as reducing the reliance on invasive and expensive procedures such as colonoscopies. The growing adoption of more economical diagnostic technologies, combined with the increasing prevalence of chronic diseases worldwide and the absence of cost-efficient alternatives, continues to drive a strong demand for IVD solutions.
